Mette Brabrand

Mette Brabrand is a Researcher in the Department of Clinical Research and Research Unit of Haematology at the University of Southern Denmark. Her work focuses on myeloproliferative neoplasms, cardiovascular associations in haematology, and clinical trial design.

• Key research areas: Myeloproliferative Neoplasms, Genetic Variation (JAK2), Cardiovascular Risk, Pharmacology
• Recent collaborations: Daliah Trial (Interferon-α vs Hydroxyurea), population-based studies on drug-cancer associations

Notable scientific contributions include epidemiological analyses of metformin/statin use in relation to myeloproliferative neoplasm risk, and genetic biomarkers for cardiovascular complications in haematological disorders.

• Awards: AstraZeneca Research Prize in Emergency Medicine 2013